Select Publications
Journal articles
2019, 'Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience', Journal of Surgical Oncology, 119, pp. 336 - 346, http://dx.doi.org/10.1002/jso.25277
,2019, 'Case report: Intraoperative thrombosis cardiac arrest in extended right hepatectomy involving use of local haemostatic agent in intraoperative cell salvage (ICS) and administration of recombinant activated factor VII (rFVIIa)', International Journal of Surgery Case Reports, 57, pp. 48 - 51, http://dx.doi.org/10.1016/j.ijscr.2019.02.042
,2019, 'Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a patient with peritoneal carcinomatosis from a pancreatic cystadenocarcinoma: A case report', International Journal of Surgery Case Reports, 63, pp. 48 - 52, http://dx.doi.org/10.1016/j.ijscr.2019.08.024
,2019, 'Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 cases', Journal of Surgical Oncology, 120, pp. 794 - 802, http://dx.doi.org/10.1002/jso.25642
,2019, 'Volume-time index is not an indicator of outcome for patients undergoing CRS/HIPEC for treatment of high-grade appendiceal carcinomatosis', Anticancer Research, 39, pp. 6813 - 6817, http://dx.doi.org/10.21873/anticanres.13897
,2019, '03:18 PM Abstract No. 280 Is microwave ablation superior to radiofrequency ablation in the treatment for pulmonary metastasis of colorectal cancer? One center’s 17-year experience in Australia', Journal of Vascular and Interventional Radiology, 30, pp. S125 - S126, http://dx.doi.org/10.1016/j.jvir.2018.12.344
,2019, '03:36 PM Abstract No. 367 An ex vivo bench and perfused liver assessment and extension of the ablation zone by “EdgeBoost” with IR-Circle: a new bipolar ablation device', Journal of Vascular and Interventional Radiology, 30, pp. S162 - S162, http://dx.doi.org/10.1016/j.jvir.2018.12.440
,2018, 'Survival difference between mucinous vs. non-mucinous colorectal cancer following cytoreductive surgery and intraperitoneal chemotherapy', International Journal of Hyperthermia, 35, pp. 298 - 304, http://dx.doi.org/10.1080/02656736.2018.1496486
,2018, 'The effect of hyperthermia (42°C) on the anti-tumoral effect of bromelain, N-acetyl cysteine, chemotherapeutic agents and their combinations - an in vitro evaluation', Journal of Peritoneum (and other serosal surfaces), http://dx.doi.org/10.4081/joper.2018.104
,2018, 'The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)', European Journal of Surgical Oncology, 44, pp. 1942 - 1948, http://dx.doi.org/10.1016/j.ejso.2018.07.003
,2018, 'Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study', European Journal of Surgical Oncology, 44, pp. 1786 - 1792, http://dx.doi.org/10.1016/j.ejso.2018.05.021
,2018, 'Impact of Concomitant Urologic Intervention on Clinical Outcomes after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy', American Journal of Clinical Oncology: Cancer Clinical Trials, 41, pp. 943 - 948, http://dx.doi.org/10.1097/COC.0000000000000414
,2018, 'Long-term survival and propensity score matched outcomes of bilateral vs. unilateral diaphragm interventions in cytoreductive surgery plus intra-peritoneal chemotherapy', Anticancer Research, 38, pp. 5917 - 5921, http://dx.doi.org/10.21873/anticanres.12936
,2018, 'Prevention of peritoneal recurrence in high-risk colorectal cancer and evidence of T4 status as a potential risk factor', ANZ Journal of Surgery, 88, pp. 975 - 981, http://dx.doi.org/10.1111/ans.14428
,2018, 'Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups', European Journal of Surgical Oncology, 44, pp. 1378 - 1383, http://dx.doi.org/10.1016/j.ejso.2018.04.023
,2018, 'Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE', Annals of Surgical Oncology, 25, pp. 1668 - 1675, http://dx.doi.org/10.1245/s10434-018-6464-z
,2018, 'Peritoneal Surface Oncology Group International (PSOGI) multicenter study on nomograms to predict overall survival in diffuse malignant peritoneal mesothelioma.', Journal of Clinical Oncology, 36, pp. e15701 - e15701, http://dx.doi.org/10.1200/jco.2018.36.15_suppl.e15701
,2018, 'Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience', Annals of Surgical Oncology, 25, pp. 1184 - 1192, http://dx.doi.org/10.1245/s10434-018-6369-x
,2018, 'Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients', Annals of Surgical Oncology, 25, pp. 1094 - 1100, http://dx.doi.org/10.1245/s10434-017-6299-z
,2018, 'CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study', Journal of Surgical Oncology, 117, pp. 725 - 736, http://dx.doi.org/10.1002/jso.24911
,2018, 'Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry', Annals of Surgical Oncology, 25, pp. 667 - 673, http://dx.doi.org/10.1245/s10434-017-6293-5
,2018, 'A randomised controlled trial to compare administration of prothrombin complex concentrate with standard haemostasis management in adult patients undergoing peritoneal cytoreductive surgery requiring massive transfusion', Pathology, 50, pp. S59 - S60, http://dx.doi.org/10.1016/j.pathol.2017.12.140
,2018, 'CRS with HIPEC for peritoneal carcinomatosis of pancreatic adenocarcinoma. What do we expect? Results of a Multicenter International Study', HPB, 20, pp. S324 - S324, http://dx.doi.org/10.1016/j.hpb.2018.06.356
,2018, 'Drug combinations for hipec after cytoreductive surgery in diffuse malignant peritoneal mesothelioma: A PSOGI registry study', European Journal of Surgical Oncology, 44, pp. e5 - e5, http://dx.doi.org/10.1016/j.ejso.2018.07.021
,2018, 'Monepantel considerably enhances the therapeutic potentials of PEGylated liposomal doxorubicin and gemcitabine in ovarian cancer: in vitro and in vivo studies.', Am J Cancer Res, 8, pp. 2064 - 2075, https://www.ncbi.nlm.nih.gov/pubmed/30416856
,2018, 'Peer review report 2 on “Dose surgical resection of hepatic metastases bring benefits to pancreatic ductal adenocarcinoma? A systematic review and meta-analysis”', International Journal of Surgery, 49, pp. 16 - 16, http://dx.doi.org/10.1016/j.ijsu.2017.11.021
,2017, 'CA 19-9 to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with epithelial appendiceal mucinous neoplasms and peritoneal dissemination undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study', European Journal of Surgical Oncology, 43, pp. 2299 - 2307, http://dx.doi.org/10.1016/j.ejso.2017.09.009
,2017, 'Early postoperative intraperitoneal chemotherapy is associated with survival benefit for appendiceal adenocarcinoma with peritoneal dissemination', European Journal of Surgical Oncology, 43, pp. 2292 - 2298, http://dx.doi.org/10.1016/j.ejso.2017.09.002
,2017, 'Reply: “Adjuvant” Hyperthermic Intraperitoneal Chemotherapy: A Call to Action', Annals of Surgical Oncology, 24, pp. 616, http://dx.doi.org/10.1245/s10434-017-6171-1
,2017, 'Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre', ANZ Journal of Surgery, 87, pp. E167 - E172, http://dx.doi.org/10.1111/ans.13231
,2017, 'Treatment-related post-operative mortality after cytoreductive surgery and perioperative intraperitoneal chemotherapy', Journal of Peritoneum (and other serosal surfaces), http://dx.doi.org/10.4081/joper.2017.65
,2017, 'Percutaneous lung ablation of pulmonary recurrence may improve survival in selected patients undergoing cytoreductive surgery for colorectal cancer with peritoneal carcinomatosis', European Journal of Surgical Oncology, 43, pp. 1939 - 1948, http://dx.doi.org/10.1016/j.ejso.2017.08.005
,2017, 'Recurrence and survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for small bowel adenocarcinoma', Anticancer Research, 37, pp. 5737 - 5742, http://dx.doi.org/10.21873/anticanres.12012
,2017, 'The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres', Annals of Surgical Oncology, 24, pp. 2465 - 2473, http://dx.doi.org/10.1245/s10434-017-5950-z
,2017, 'Allogenic Blood Transfusion Is an Independent Predictor of Poorer Peri-operative Outcomes and Reduced Long-Term Survival after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a Review of 936 Cases', Journal of Gastrointestinal Surgery, 21, pp. 1318 - 1327, http://dx.doi.org/10.1007/s11605-017-3444-8
,2017, 'Splenectomy is an independent risk factor for poorer perioperative outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An analysis of 936 procedures', Journal of Gastrointestinal Oncology, 8, pp. 737 - 746, http://dx.doi.org/10.21037/jgo.2017.07.09
,2017, 'Assessment of a novel mucolytic solution for dissolving mucus in pseudomyxoma peritonei: An ex vivo and in vitro study', Pleura and Peritoneum, 2, pp. 111 - 117, http://dx.doi.org/10.1515/pp-2017-0013
,2017, 'Repeat cytoreductive surgery with or without perioperative intraperitoneal chemotherapy for peritoneal surface malignancy', American Journal of Surgery, 213, pp. 1024 - 1030, http://dx.doi.org/10.1016/j.amjsurg.2016.09.046
,2017, 'Systematic review and a meta-analysis of hospital and surgeon volume/outcome relationships in colorectal cancer surgery', Journal of Gastrointestinal Oncology, 8, pp. 534 - 546, http://dx.doi.org/10.21037/jgo.2017.01.25
,2017, 'The use of carbon dioxide insufflation to facilitate identification of intestinal injuries in patients undergoing cytoreductive surgery and intraperitoneal chemotherapy', Techniques in Coloproctology, 21, pp. 479 - 480, http://dx.doi.org/10.1007/s10151-017-1644-6
,2017, 'Expression pattern of miR-451 and its target MIF (macrophage migration inhibitory factor) in colorectal cancer', Journal of clinical pathology, 70, pp. 308 - 312, http://dx.doi.org/10.1136/jclinpath-2016-203972
,2017, 'Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients with Appendiceal Mucinous Neoplasm with Peritoneal Dissemination', Diseases of the Colon and Rectum, 60, pp. 360 - 367, http://dx.doi.org/10.1097/DCR.0000000000000719
,2017, 'Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy', Journal of Surgical Oncology, 115, pp. 417 - 424, http://dx.doi.org/10.1002/jso.24543
,2017, 'Gastric perforation following cytoreductive surgery and perioperative intraperitoneal chemotherapy: A case series of six', World Journal of Surgical Oncology, 15, pp. 44, http://dx.doi.org/10.1186/s12957-017-1114-7
,2017, 'Is mucin a determinant of peritoneal dissemination of gastrointestinal cancer? Analysis of mucin depletion in two preclinical models', Clinical and Translational Oncology, 19, pp. 261 - 264, http://dx.doi.org/10.1007/s12094-016-1519-8
,2017, 'Early Postoperative Intraperitoneal Chemotherapy for Low-Grade Appendiceal Mucinous Neoplasms with Pseudomyxoma Peritonei: Is it Beneficial?', Annals of Surgical Oncology, 24, pp. 176 - 183, http://dx.doi.org/10.1245/s10434-016-5529-0
,2017, 'Evaluation of carcinoembryonic antigen (CEA) density as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases', European Radiology, 27, pp. 128 - 137, http://dx.doi.org/10.1007/s00330-016-4352-0
,2017, 'Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis', ANZ Journal of Surgery, 87, pp. 49 - 54, http://dx.doi.org/10.1111/ans.13280
,2017, 'Mucins in pancreatic cancer: Biological role, implications in carcinogenesis and applications in diagnosis and therapy', American Journal of Cancer Research, 7, pp. 1372 - 1383
,2017, 'Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis', European Journal of Surgical Oncology, 43, pp. 144 - 149, http://dx.doi.org/10.1016/j.ejso.2016.09.015
,